Aurinia Pharmaceuticals Inc. — All Filings
581 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
4/A
40-F
40-F/A
40FR12B
40FR12B/A
6-K
6-K/A
8-K
8-K/A
ARS
CERTNAS
D
DEF 14A
DEFA14A
EFFECT
F-10
F-10/A
F-X
FWP
PRE 14A
PX14A6G
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SUPPL
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001214659-26-003784 | Mar 25, 2026 | — |
| 8-K | 8-K | 0001600620-26-000026 | Mar 23, 2026 | Mar 20, 2026 |
| 4 | FORM 4 | 0001600620-26-000024 | Mar 10, 2026 | Mar 6, 2026 |
| 4 | — | 0001178579-26-000001 | Mar 3, 2026 | Feb 27, 2026 |
| SCHEDULE 13D/A | — | 0001214659-26-002769 | Mar 3, 2026 | — |
| 4 | FORM 4 | 0001600620-26-000023 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | FORM 4 | 0001600620-26-000022 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | FORM 4 | 0001600620-26-000021 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | FORM 4 | 0001600620-26-000020 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | FORM 4 | 0001600620-26-000019 | Mar 3, 2026 | Feb 27, 2026 |
| 10-K | 10-K | 0001600620-26-000017 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001600620-26-000015 | Feb 26, 2026 | — |
| 4 | FORM 4 | 0001636642-26-000002 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | FORM 4 | 0001363683-26-000002 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | FORM 4 | 0001746372-26-000002 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | FORM 4 | 0001837798-26-000002 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | FORM 4 | 0002044006-26-000002 | Feb 3, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001600620-26-000005 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001600620-26-000004 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001600620-26-000003 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001600620-26-000002 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001600620-25-000110 | Nov 24, 2025 | Nov 21, 2025 |
| 4 | FORM 4 | 0001370348-25-000004 | Nov 24, 2025 | Nov 21, 2025 |
| 8-K | 8-K | 0001600620-25-000108 | Nov 4, 2025 | — |
| 10-Q | 10-Q | 0001600620-25-000106 | Nov 4, 2025 | Sep 30, 2025 |
| SCHEDULE 13D/A | — | 0001104659-25-077809 | Aug 13, 2025 | — |
| 4 | — | 0001415889-25-021066 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001600620-25-000095 | Aug 5, 2025 | Aug 1, 2025 |
| 10-Q | 10-Q | 0001600620-25-000092 | Jul 31, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001600620-25-000090 | Jul 31, 2025 | — |
| 8-K | 8-K | 0001600620-25-000083 | Jun 30, 2025 | — |
| 4 | FORM 4 | 0001600620-25-000078 | May 16, 2025 | — |
| 4 | FORM 4 | 0001600620-25-000077 | May 16, 2025 | — |
| 4 | FORM 4 | 0001600620-25-000076 | May 16, 2025 | — |
| 4 | FORM 4 | 0001600620-25-000075 | May 16, 2025 | — |
| 3 | FORM 3 | 0001600620-25-000074 | May 16, 2025 | May 15, 2025 |
| 3 | FORM 3 | 0001600620-25-000073 | May 16, 2025 | May 15, 2025 |
| S-8 | S-8 | 0001600620-25-000072 | May 16, 2025 | — |
| 8-K | 8-K | 0001600620-25-000057 | May 15, 2025 | — |
| 10-Q | 10-Q | 0001600620-25-000049 | May 12, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001600620-25-000047 | May 12, 2025 | — |
| DEFA14A | DEFA14A | 0001600620-25-000040 | Apr 30, 2025 | — |
| DEFA14A | DEFA14A | 0001600620-25-000036 | Apr 29, 2025 | — |
| DEF 14A | DEF 14A | 0001600620-25-000032 | Apr 17, 2025 | May 15, 2025 |
| 4 | FORM 4 | 0001600620-25-000026 | Mar 7, 2025 | — |
| 4 | FORM 4 | 0001600620-25-000024 | Mar 4, 2025 | Feb 28, 2025 |
| 4 | FORM 4 | 0001600620-25-000022 | Mar 4, 2025 | Feb 28, 2025 |
| 4 | FORM 4 | 0001600620-25-000020 | Mar 4, 2025 | Feb 28, 2025 |
| 4 | FORM 4 | 0001600620-25-000019 | Mar 4, 2025 | Feb 28, 2025 |
| 4 | FORM 4 | 0001600620-25-000018 | Mar 4, 2025 | Feb 28, 2025 |